Lisa Oliver

5.3k total citations · 1 hit paper
102 papers, 4.2k citations indexed

About

Lisa Oliver is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Lisa Oliver has authored 102 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Molecular Biology, 25 papers in Cancer Research and 24 papers in Oncology. Recurrent topics in Lisa Oliver's work include Cell death mechanisms and regulation (32 papers), RNA Interference and Gene Delivery (18 papers) and Glioma Diagnosis and Treatment (16 papers). Lisa Oliver is often cited by papers focused on Cell death mechanisms and regulation (32 papers), RNA Interference and Gene Delivery (18 papers) and Glioma Diagnosis and Treatment (16 papers). Lisa Oliver collaborates with scholars based in France, United States and United Kingdom. Lisa Oliver's co-authors include François M. Vallette, Pierre‐François Cartron, Khaled Méflah, Philippe Juin, Lisenn Lalier, Stéphen Manon, Claire Pecqueur, Dominique Heymann, Muriel Priault and Olivier D. Christophe and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Experimental Medicine and The Journal of Cell Biology.

In The Last Decade

Lisa Oliver

101 papers receiving 4.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Three-dimensional in vitro culture models in oncology research

2022 161 citations Marie‐Françoise Heymann, François M. Vallette et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lisa Oliver France	40	2.6k	839	838	536	466	102	4.2k
Ivica Rubelj Croatia	15	3.8k 1.4×	705 0.8×	1.1k 1.3×	437 0.8×	872 1.9×	37	6.8k
Calvin D. Roskelley Canada	13	3.9k 1.5×	779 0.9×	1.3k 1.6×	436 0.8×	949 2.0×	18	6.9k
Antonino Passaniti United States	39	3.6k 1.4×	1.5k 1.7×	1.1k 1.3×	382 0.7×	699 1.5×	85	5.6k
John D. Hooper Australia	35	1.9k 0.7×	1.1k 1.3×	1.1k 1.3×	817 1.5×	406 0.9×	120	4.1k
Jang‐Soo Chun South Korea	45	2.6k 1.0×	1.1k 1.3×	629 0.8×	235 0.4×	542 1.2×	112	5.5k
Margit Rosner Austria	28	2.3k 0.9×	377 0.4×	710 0.8×	384 0.7×	690 1.5×	96	4.0k
Annalisa Pession Italy	41	3.1k 1.2×	1.2k 1.4×	912 1.1×	1.0k 1.9×	473 1.0×	144	5.8k
Jean Viallet Canada	39	3.5k 1.3×	820 1.0×	1.6k 1.9×	316 0.6×	430 0.9×	102	5.6k
Ross D. Hannan Australia	53	6.4k 2.4×	833 1.0×	1.4k 1.6×	303 0.6×	538 1.2×	151	8.6k
Jeffrey A. Medin Canada	40	3.0k 1.1×	409 0.5×	1.2k 1.5×	332 0.6×	1.2k 2.5×	181	5.8k

Countries citing papers authored by Lisa Oliver

Since Specialization

Citations

This map shows the geographic impact of Lisa Oliver's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa Oliver with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa Oliver more than expected).

Fields of papers citing papers by Lisa Oliver

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisa Oliver. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa Oliver. The network helps show where Lisa Oliver may publish in the future.

Co-authorship network of co-authors of Lisa Oliver

This figure shows the co-authorship network connecting the top 25 collaborators of Lisa Oliver. A scholar is included among the top collaborators of Lisa Oliver based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisa Oliver. Lisa Oliver is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Oliver, Lisa, Catherine Gratas, Pierre‐François Cartron, et al.. (2024). Transcriptional landscape of the interaction of human Mesenchymal Stem Cells with Glioblastoma in bioprinted co-cultures. Stem Cell Research & Therapy. 15(1). 424–424. 1 indexed citations

Loussouarn, Delphine, et al.. (2023). Spatial Distribution of Immune Cells in Primary and Recurrent Glioblastoma: A Small Case Study. Cancers. 15(12). 3256–3256. 7 indexed citations

Oliver, Lisa, Gabriel F. Calvo, Juan Belmonte-Beitia, et al.. (2023). A Simple 3D Cell Culture Method for Studying the Interactions between Human Mesenchymal Stromal/Stem Cells and Patients Derived Glioblastoma. Cancers. 15(4). 1304–1304. 3 indexed citations

Christophe, Olivier D., Lisa Oliver, Lisenn Lalier, & François M. Vallette. (2021). Drug Resistance in Glioblastoma: The Two Faces of Oxidative Stress. Frontiers in Molecular Biosciences. 7. 620677–620677. 130 indexed citations

Belmonte-Beitia, Juan, Gabriel F. Calvo, Catherine Gratas, et al.. (2020). Mitochondria transfer from tumor-activated stromal cells (TASC) to primary Glioblastoma cells. Biochemical and Biophysical Research Communications. 533(1). 139–147. 60 indexed citations

Joalland, Marie‐Pierre, Lisa Oliver, Claire Pecqueur, et al.. (2020). Sphingolipid distribution at mitochondria-associated membranes (MAMs) upon induction of apoptosis. Journal of Lipid Research. 61(7). 1025–1037. 40 indexed citations

Chauvin, Cynthia, Noémie Joalland, Ulrich Jarry, et al.. (2019). NKG2D Controls Natural Reactivity of Vγ9Vδ2 T Lymphocytes against Mesenchymal Glioblastoma Cells. Clinical Cancer Research. 25(23). 7218–7228. 30 indexed citations

Fleurence, Julien, Sophie Fougeray, Émilie Pinault, et al.. (2019). Impairing temozolomide resistance driven by glioma stem‐like cells with adjuvant immunotherapy targeting O‐acetyl GD2 ganglioside. International Journal of Cancer. 146(2). 424–438. 25 indexed citations

Oizel, Kristell, Cynthia Chauvin, Lisa Oliver, et al.. (2017). Efficient Mitochondrial Glutamine Targeting Prevails Over Glioblastoma Metabolic Plasticity. Clinical Cancer Research. 23(20). 6292–6304. 71 indexed citations

10.

Oizel, Kristell, Catherine Gratas, Arulraj Nadaradjane, et al.. (2015). D-2-Hydroxyglutarate does not mimic all the IDH mutation effects, in particular the reduced etoposide-triggered apoptosis mediated by an alteration in mitochondrial NADH. Cell Death and Disease. 6(3). e1704–e1704. 29 indexed citations

11.

Cartron, Pierre‐François, et al.. (2014). Metaxins 1 and 2, two proteins of the mitochondrial protein sorting and assembly machinery, are essential for Bak activation during TNF alpha triggered apoptosis. Cellular Signalling. 26(9). 1928–1934. 28 indexed citations

12.

Lalier, Lisenn, Pierre‐François Cartron, Olivier D. Christophe, et al.. (2010). Prostaglandins antagonistically control Bax activation during apoptosis. Cell Death and Differentiation. 18(3). 528–537. 40 indexed citations

13.

Ménoret, Emmanuelle, Patricia Gomez‐Bougie, Sylvanie Surget, et al.. (2009). Mcl‐1^128–350 fragment induces apoptosis through direct interaction with Bax. FEBS Letters. 584(3). 487–492. 12 indexed citations

14.

Chipoy, Céline, Bénédicte Brounais, Valérie Trichet, et al.. (2007). Sensitization of osteosarcoma cells to apoptosis by oncostatin M depends on STAT5 and p53. Oncogene. 26(46). 6653–6664. 43 indexed citations

15.

Cartron, Pierre‐François, Philippe Juin, Lisa Oliver, Khaled Méflah, & François M. Vallette. (2003). Impact of proapoptotic proteins Bax and Bak in tumor progression and response to treatment. Expert Review of Anticancer Therapy. 3(4). 563–570. 31 indexed citations

16.

Oliver, Lisa, et al.. (1999). The C-Terminus of bax Is Not a Membrane Addressing/Anchoring Signal. Biochemical and Biophysical Research Communications. 260(3). 582–591. 43 indexed citations

17.

Heymann, Marie‐Françoise, Olivier Boisteau, Lisa Oliver, et al.. (1997). 5-fluorouracil-resistant colonic tumors are highly responsive to sodium butyrate/interleukin-2 bitherapy in rats. International Journal of Cancer. 73(6). 924–928. 11 indexed citations

18.

Oliver, Lisa, Olivier Goureau, Yves Courtois, & Marc Vigny. (1996). Accumulation of NO synthase (type-I) at the neuromuscular junctions in adult mice. Neuroreport. 7(4). 924–926. 32 indexed citations

19.

Jacquemin, E., Laurent Jonet, Lisa Oliver, et al.. (1993). Developmental regulation of acidic fibroblast growth factor (aFGF) expression in bovine retina. The International Journal of Developmental Biology. 37(3). 417–423. 17 indexed citations

20.

Oliver, Lisa, et al.. (1992). Immunolocalization of acidic and basic fibroblast growth factors during mouse odontogenesis. The International Journal of Developmental Biology. 36(3). 381–389. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact